Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Nephrol ; 79(4): 326-9, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23537684

RESUMO

Mercury is a known cause of nephrotic syndrome and the underlying renal pathology in most of the reported cases was membranous nephropathy. We describe here 4 cases of minimal change disease following exposure to mercury-containing skin lightening cream for 2 - 6 months. The mercury content of the facial creams was very high (7,420 - 30,000 parts per million). All patients were female and presented with nephrotic syndrome and heavy proteinuria (8.35 - 20.69 g/d). The blood and urine mercury levels were 26 - 129 nmol/l and 316 - 2,521 nmol/d, respectively. Renal biopsy revealed minimal change disease (MCD) in all patients. The use of cosmetic cream was stopped and chelation therapy with D-penicillamine was given. Two patients were also given steroids. The time for blood mercury level to normalize was 1 - 7 months, whereas it took longer for urine mercury level to normalize (9 - 16 months). All patients had complete remission of proteinuria and the time to normalization of proteinuria was 1 - 9 months. Mercury-containing skin lightening cream is hazardous because skin absorption of mercury can cause minimal change disease. The public should be warned of the danger of using such products. In patients presenting with nephrotic syndrome, a detailed history should be taken, including the use of skin lightening cream. With regard to renal pathology, apart from membranous nephropathy, minimal change disease should be included as another pathological entity caused by mercury exposure or intoxication.


Assuntos
Rim/efeitos dos fármacos , Compostos de Mercúrio/efeitos adversos , Nefrose Lipoide/induzido quimicamente , Preparações Clareadoras de Pele/efeitos adversos , Pigmentação da Pele/efeitos dos fármacos , Administração Cutânea , Adulto , Biópsia , Quelantes/uso terapêutico , Feminino , Humanos , Rim/metabolismo , Rim/patologia , Compostos de Mercúrio/administração & dosagem , Compostos de Mercúrio/sangue , Compostos de Mercúrio/urina , Pessoa de Meia-Idade , Nefrose Lipoide/diagnóstico , Nefrose Lipoide/tratamento farmacológico , Nefrose Lipoide/metabolismo , Penicilamina/uso terapêutico , Proteinúria/induzido quimicamente , Absorção Cutânea , Creme para a Pele , Preparações Clareadoras de Pele/administração & dosagem , Preparações Clareadoras de Pele/metabolismo , Esteroides/uso terapêutico , Fatores de Tempo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA